Index your Journal on RJRIndex — A product by ResearchJournalRank.com Index Now
34,970+ Journals Indexed Journal Suggester  |  Paper Finder  |  Compare Journals
Home › Immunometabolism (United States)

Immunometabolism (United States)

Q2 Journal Scopus Active Journal
Country
United States
Northern America
Subject Area and Category
Medicine
└ Endocrinology, Diabetes and Metabolism Q2
└ Immunology and Allergy Q2
SJR 2025
1.165
Q2
SJR Score
H-Index
20
Citations / Doc (2yr)
3.62
Total Docs. (latest)
23
Total Citations (3yr)
215
Publication type
Journals
ISSN
26330407
Coverage
2019-2025
Journal Rank
#3,820
Advertisement

Subject Categories

Endocrinology, Diabetes and Metabolism Q2
Immunology and Allergy Q2

Subject Areas

Aims & Scope

Immunometabolism (ISSN: 2633-0407) is a quarterly international open-access peer-reviewed journal reporting latest advances in a rapidly expanding field of investigation linking the disciplines of immunology (including immune cell function) and metabolism (including metabolic regulation). In this new journal, we aim to publish articles that describe molecular processes that impact health through cross talk between metabolic and immune function. The underlying basic mechanisms and potential therapeutic applications will be a focus. Topics include but are not limited to: • Infection and host metabolic adaptations • Chronic inflammation and metabolic disease • Metabolic regulation and disruption in immune cells • Metabolic aspects of Cancer immunity and immunotherapy • Metabolic aspects of Neurodegeneration and inflammation • Nutrient sensing and microbiome-host interactions. The journal accepts: Reviews, Original Articles, Technical Notes, Editorials, News and Views, Letters to the Editors, as well as Conference Announcements and Book Reviews. Controversies and debates are also welcomed. A Special Section of the journal may be devoted for publishing accelerated papers considered as a breakthrough in the field. Special editions of the journal will be occasionally published on a focus topic which will have a Guest Editor.

Abstracting & Indexing

Scopus Google Scholar Web of Science

Detailed Metrics

Total Docs. (latest) 23
Total Docs. (3 years) 64
Total Refs. 1,588
Total Citations (3 years) 215
Citable Docs. (3 years) 62
Citations / Doc. (2 years) 3.62
Ref. / Doc. 69.04
% Female 40.6%

Metrics Visualization

Latest year data vs 3-year cumulative figures

Publication & Citation Trend

Loading trend data from Crossref...

Top 10 Most Cited Articles

Loading articles...

Frequently Asked Questions

What is the impact factor of Immunometabolism (United States)?

The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Immunometabolism (United States) has an SJR of 1.165 and is ranked Q2.

What is the SJR and quartile of Immunometabolism (United States)?

Immunometabolism (United States) has an SJR (SCImago Journal Rank) of 1.165 and its best quartile is Q2.

What is the H-index of Immunometabolism (United States)?

The H-index of Immunometabolism (United States) is 20, meaning 20 of its articles have each been cited at least 20 times.

Is Immunometabolism (United States) indexed in Scopus?

Yes. Immunometabolism (United States) is active in Scopus (Scopus Source List, August 2026).

Advertisement

Journal Information

SJR1.165
Best QuartileQ2
H Index20
ISSN26330407
PublisherLippincott Williams and Wilkins
CountryUnited States
RegionNorthern America
Coverage2019-2025
Open AccessNo
TypeJournal
Rank#3,820

Embed This Journal

Add this journal's ranking badge to your website:

<iframe src="https://researchjournalrank.com/widget.php?id=3647" style="border:1px solid #e0e0e0;border-radius:8px;width:100%;max-width:320px;height:200px" frameborder="0"></iframe>
Preview:

Researcher Reviews

Write a Review

No reviews yet for this journal.

Be the first to share your experience!

Share Your Experience

Your review will be published after moderation. Email will not be displayed publicly.

★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★